Large Cell Neuroendocrine Lung Carcinoma Transformation as an Acquired Resistance Mechanism to Osimertinib

J Thorac Oncol. 2017 Nov;12(11):e184-e186. doi: 10.1016/j.jtho.2017.07.019.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acrylamides
  • Aniline Compounds
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Large Cell / drug therapy*
  • Carcinoma, Large Cell / pathology
  • Drug Resistance, Neoplasm / drug effects*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Piperazines / pharmacology
  • Piperazines / therapeutic use*

Substances

  • Acrylamides
  • Aniline Compounds
  • Antineoplastic Agents
  • Piperazines
  • osimertinib